These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35114742)

  • 21. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2.
    Riester E; Majchrzak M; Mühlbacher A; Tinguely C; Findeisen P; Hegel JK; Laimighofer M; Rank CM; Schönfeld K; Langen F; Laengin T; Niederhauser C
    Infect Dis Ther; 2021 Dec; 10(4):2381-2397. PubMed ID: 34368915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.
    Egger M; Bundschuh C; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():18-21. PubMed ID: 32485155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
    Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
    Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
    Riester E; Findeisen P; Hegel JK; Kabesch M; Ambrosch A; Rank CM; Pessl F; Laengin T; Niederhauser C
    J Virol Methods; 2021 Nov; 297():114271. PubMed ID: 34461153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys
    Delgado JF; Vidal M; Julià G; Navarro G; Serrano RM; van den Eynde E; Navarro M; Calvet J; Gratacós J; Espasa M; Peña P
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil.
    Andreata-Santos R; Machado RRG; Alves RPDS; Sales NS; Soares CP; Rodrigues KB; Silva MO; Favaro MTP; Rodrigues-Jesus MJ; Yamamoto MM; de Andrade JB; Fock RA; Margarido PFR; Carvalho CRG; Boscardin SB; Durigon EL; Ferreira LCS
    Front Cell Infect Microbiol; 2022; 12():787411. PubMed ID: 35719329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay.
    Pighi L; Henry BM; De Nitto S; Gianfilippi G; Salvagno GL; Plebani M; Lippi G
    Clin Chem Lab Med; 2023 Jul; 61(8):1506-1510. PubMed ID: 36883744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies.
    Weber MC; Risch M; Thiel SL; Grossmann K; Nigg S; Wohlwend N; Lung T; Hillmann D; Ritzler M; Ferrara F; Bigler S; Egli K; Bodmer T; Imperiali M; Salimi Y; Fleisch F; Cusini A; Heer S; Renz H; Paprotny M; Kohler P; Vernazza P; Risch L; Kahlert CR
    Dis Markers; 2021; 2021():8810196. PubMed ID: 33532006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
    National SARS-CoV-2 Serology Assay Evaluation Group
    Lancet Infect Dis; 2020 Dec; 20(12):1390-1400. PubMed ID: 32979318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
    Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
    J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
    Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers.
    Heffernan E; Kennedy L; Hannan MM; Ramlaul N; Denieffe S; Courtney G; Watt A; Hurley J; Lynch M; Fitzgibbon M
    Ann Clin Biochem; 2021 Sep; 58(5):496-504. PubMed ID: 33845592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LumiraDX SARS-CoV-2 Antigen Test for Diagnosing Acute SARS-CoV-2 Infection: Critical Literature Review and Meta-Analysis.
    Lippi G; Henry BM; Plebani M
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of the antibody response in patients with COVID-19 using automated high-throughput immunoassays.
    Kubota K; Kitagawa Y; Matsuoka M; Imai K; Orihara Y; Kawamura R; Sakai J; Ishibashi N; Tarumoto N; Takeuchi S; Maesaki S; Maeda T
    Diagn Microbiol Infect Dis; 2021 Jul; 100(3):115370. PubMed ID: 33744623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.